Cargando…
Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994234/ https://www.ncbi.nlm.nih.gov/pubmed/33625716 http://dx.doi.org/10.1007/s40264-021-01055-1 |
| _version_ | 1783669711140028416 |
|---|---|
| author | Giugliano, Robert P. De Caterina, Raffaele Yamashita, Takeshi |
| author_facet | Giugliano, Robert P. De Caterina, Raffaele Yamashita, Takeshi |
| author_sort | Giugliano, Robert P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7994234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79942342021-04-16 Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” Giugliano, Robert P. De Caterina, Raffaele Yamashita, Takeshi Drug Saf Letter to the Editor Springer International Publishing 2021-02-24 2021 /pmc/articles/PMC7994234/ /pubmed/33625716 http://dx.doi.org/10.1007/s40264-021-01055-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter to the Editor Giugliano, Robert P. De Caterina, Raffaele Yamashita, Takeshi Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title | Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title_full | Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title_fullStr | Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title_full_unstemmed | Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title_short | Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” |
| title_sort | comment on: “direct oral anticoagulants and interstitial lung disease: emerging clues from pharmacovigilance” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994234/ https://www.ncbi.nlm.nih.gov/pubmed/33625716 http://dx.doi.org/10.1007/s40264-021-01055-1 |
| work_keys_str_mv | AT giuglianorobertp commentondirectoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance AT decaterinaraffaele commentondirectoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance AT yamashitatakeshi commentondirectoralanticoagulantsandinterstitiallungdiseaseemergingcluesfrompharmacovigilance |